Prognostic value of body mass index before treatment for laryngeal squamous cell carcinoma

Zhao-Qu Li*, Lan Zou*, Tian-Run Liu*, An-Kui Yang

1Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou 510060, China;2Department of Head and Neck Surgery, Sun Yat-sen University Cancer Center, Guangzhou 510060, China;3Department of Otorhinolaryngology Head and Neck Surgery, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou 510060, China

ORIGINAL ARTICLE

Prognostic value of body mass index before treatment for laryngeal squamous cell carcinoma

Zhao-Qu Li1,2*, Lan Zou1,2*, Tian-Run Liu3*, An-Kui Yang1,2

1Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou 510060, China;2Department of Head and Neck Surgery, Sun Yat-sen University Cancer Center, Guangzhou 510060, China;3Department of Otorhinolaryngology Head and Neck Surgery, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou 510060, China

Objective: Patients with head and neck cancer ofen sufer from malnutrition. Tis study aims to investigate the infuence of body mass index (BMI) on the prognosis of laryngeal squamous cell carcinoma (LSCC).

Methods: A total of 473 patients with LSCC initially treated at Sun Yat-sen University Cancer Center between January 2005 and July 2009 were retrospectively reviewed. Survival analysis was performed by the Kaplan-Meier method and Cox regression model.

Results: Low BMI before treatment was signifcantly associated with poor overall survival in patients with LSCC (P＜0.001). BMI was an independent prognostic factor for patients with LSCC.

Conclusion: Leanness before treatment was associated with poor prognosis in patients with LSCC. Good nutritional status is favorable to improve survival in patients with LSCC.

Prognosis; nutrition; body mass index (BMI); laryngeal squamous cell carcinoma (LSCC)

Introduction

Head and neck cancer is the sixth most common cancer worldwide, and the most common malignancy of the head and neck is laryngeal squamous cell carcinoma (LSCC)1,2. This disease often involves male patients older than 50 years old. LSCC seriously afects the life quality of patients, and the 5-year survival is about 60% regardless of stage, treatment strategy, and tumor location1,3.

Several factors are associated with the prognosis of LSCC, including smoking and alcohol consumption, human papillomavirus and Epstein-Barr virus infections, radiation, and heredity1,2. Patients with head and neck cancer ofen sufer from malnutrition. Nutritional status has been reported to be associated with risk4and survival in several types of head and neck cancer, such as oral5-7and pharyngeal cancers8. Understanding the prognostic value of nutritional status in patients with LSCC bears clinical signifcance.

Body mass index (BMI), a measure of relative weight based on the mass and height of an individual, is widely used to evaluate nutritional status. BMI has been identifed as a possible risk factor for several cancers. Several studies have suggested that high BMI indicates a signifcantly beter prognosis than low BMI for patients with oral cavity and oropharyngeal cancer5,6,8,9, whereas other researchers reported conficting results7. However, the infuence of BMI on the prognosis of head and neck cancer, including LSCC, remains controversial. In the present study, we investigated the prognostic infuence of BMI on LSCC.

Materials and methods

Patients and follow up

We retrospectively reviewed 473 patients diagnosed with LSCC and initially treated at Sun Yat-sen University Cancer Center (SYSUCC) between January 2005 and July 2009. Te patients consisted of 456 males (96%) and 17 females (4%). Their ages ranged from 24 to 86 years (median, 59 years). The clinical characteristics of the patients are summarized in Table 1. No patient had distant metastasis prior to treatment. Among the 473 patients, 430 underwent surgery, 17 received chemotherapy and radiation treatment afer surgery, 32 received radiotherapy, and 21 received chemotherapy after surgery. Surgical marginswere free of disease.

Table 1 Association of BMI status with the clinical characteristics of patients with LSCC

Of the 43 patients who did not undergo surgery, 11 received radiation treatment, 22 underwent chemotherapy, and 10 underwent both chemotherapy and radiation treatment.

The survival time was defined as the period from the date of the initial treatment to the date of death or final follow up (July 2014). This study followed the Declaration of Helsinki on medical protocol and ethics, and it was approved by the Institutional Review Board at SYSUCC. Written informed consent was obtained from all patients for the publication of this study.

Criteria for nutritional status

The nutritional status of the patients was classified by BMI in accordance with Asian-specific BMI cutoff points as follows: overweight (≥25 kg/m2), normal weight (≥18.5 and ＜25 kg/m2), or underweight (＜18.5 kg/m2)10. The BMI data were obtained before treatment.

Statistical analysis

The Chi-square test and Kruskal-Wallis H test were used for bivariate analysis. Kaplan-Meier and log-rank tests were used for survival analysis. Multivariate Cox regression analysis was performed for significant variables found using univariate analysis. SPSS 16.0 was used for all analyses. P＜0.05 was considered statistically signifcant.

Results

Patient characteristics and bivariate analysis

A total of 473 patients participated in this study. Te clinicopathological characteristics of the patients are summarized in Table 1. Among the 473 patients, 83 (17%) were underweight, 296 (63%) were of normal weight, and 94 (20%) were overweight based on their BMI. The groups of patients with different BMI statuses showed similar distributions of host and tumor factors, including age, gender, smoking and alcohol intake, and pathology grade. Patients with low BMI showed a high incidence of advanced T stage (47.0% vs. 32.5% vs. 24.5%, P=0.029) and N stage (25.3% vs. 11.8% vs. 9.6%, P＜0.001; Table 1).

All patients were divided into the survival and non-survival groups. The survival group consisted of 332 patients (70%), and the non-survival group comprised 141 patients (30%). Te bivariate analysis of factors between the groups is presented in Table 2. The two groups showed significant differences in age, smoking and alcohol intake, T stage, N stage, pathology grade, treatment strategy, tumor location, and BMI status. However, no significant difference was found in gender between the two groups.

Prognostic value of BMI

The overall 5-year survival rate of these patients was 72.3%. Figure 1 reveals that the underweight patients had the lowest survival, whereas the overweight patients had the best survival (P＜0.001). The 5-year overall survival rates of the overweight group, normal weight group, and underweight group were 87.2%, 78.0%, and 34.9%, respectively. Te median survival time of the underweight group was 29.6 months.

The Cox proportional hazards model was used to verify whether the BMI status and other variables are independent prognostic factors for LSCC patients. Univariate analysis showed that age, history of smoking and alcohol intake, T stage, N stage, pathology grade, tumor location, treatment strategy, and BMI were associated with survival in patients with LSCC. Multivariate analysis of these variables showed that age, history of smoking and alcohol intake, T stage, N stage, pathology grade, treatment strategy, and BMI were independent prognostic factors for patients with LSCC, and low BMI was significantly associated with poor prognosis (Table 3).

Discussion

Our study demonstrated that BMI was significantly associated with the prognosis of LSCC, and low BMI before treatment predicted poor prognosis in patients with LSCC.

Malnutruitional status is reportedly associated with poor prognosis in several types of cancers4-8,11. In these studies, leanness was found to be associated with increased risk for head and neck cancer regardless of the smoking and drinking status, and it was reported as an early marker of oral and pharyngeal cancer4-8. For example, oral cancer patients with a BMI ＜22.8 kg/m2have poor prognosis, and weight loss can predict poor prognosis in recurrent oral and oropharyngeal carcinoma5,6. A previous retrospective analysis reported that patients with head and neck cancer and preoperative weight loss greater than 5% show poor outcome11. Notably, a study by Iyengar et al.7indicated that obesity is an independent predictor of increased risk of death for patients with early-stage oral tongue cancer. These conflicting results may be due to an inadequate sample size and inconsistent BMI cutof values. Tese studies also found various tumor sites in the oral cavity, oropharynx, and larynx with various types of histopathology. In the current study, a total of 473 patientsdiagnosed with LSCC were analyzed, and the patients were classified according to Asian-specific BMI cutoff values. We found that low BMI was significantly associated with poor survival in LSCC, which was in agreement with previous data.

Table 2 Bivariate descriptive analysis of patients with LSCC

Figure 1 Kaplan-Meier curves for overall survival according to BMI.

Malnutrition commonly occurs in patients with head and neck cancer, particularly in laryngeal cancer, which seriously affects the quality of life and nutritional status of the patient. Thus, weight loss before treatment is associated with poor prognosis. In China, underweight patients are associated with low income and education. These patients are less likely to receive proper treatment at an early stage. In addition, good nutritional status can improve survival by strengthening immunity and helping patients develop a high tolerance for extended therapeutic periods. However, our conclusion requires further demonstration. We found that patients with low BMI showed an increased incidence of advanced T and N stages,which may also contribute to decreased survival in patients with low BMI.

Table 3 Univariate and multivariate Cox regression analysis for overall survival in patients with LSCC

The present study demonstrated that patients over 60 years old exhibited low survival rates. Aging patients with oral tongue cancer have been reported to have high disease-specifc mortality12. This finding suggested increased vulnerability to deterioration of nutritional or physical status among old patients. Heavy tobacco and alcohol consumption were determined to be adverse prognostic factors in patients with head and neck cancer, including laryngeal cancer13. Another study identified heavy alcohol consumption as a risk factor for malnutrition14. Postoperative complications have also been reported to be associated with poor prognosis in patients with oral cancer15. Te present study found similar factors that could contribute to the advanced disease stage or poor general condition, both of which could increase the risk of developing complications. Developing complications would inevitably delay the administration of standard therapy, leading to recurrence or distal metastasis. Recurrence or distal metastasis may negatively affect initial treatment. Consequently, patients with low BMI have poor prognosis5.

The molecular and cellular mechanisms by which BMI affects the prognosis of cancer are complicated and unclear. Several studies have shown that a specifc enteral nutrition formula containing n-3 faty acid can prevent the deterioration of nutritional status during chemoradiation therapy for head and neck cancer; triglycerides have also been reported to promote cancer cell proliferation, and this anti-apoptotic activity is probably due to the generation of reactive oxygen species and oxidative stress, which leads to DNA damage16,17. Levels of adipokine, leptin, and adiponectin influence obesity and several signal transduction pathways involved in cell survival18. Another study reported that obesity induces insulin-resistance through the accumulation of macrophages that secrete inflammatory mediators, such as tumor necrosis factor-α, interleukin-6, and prostaglandin E219. The insulin receptor activating signaling pathways are also associated with invasion and metastasis of malignant tumors20. However, the mechanisms require further study.

Conclusion

Our study proved that BMI was an independent prognostic factor for patients with LSCC, and low BMI before treatment could predict poor prognosis for patients with LSCC. Good nutritional status could improve survival in patients with LSCC. However, our study was limited by the retrospective design. Thus, further studies are necessary to verify the correlation between BMI and the prognosis of LSCC.

Acknowledgements

This work was supported by the Science and Technology Planning Project of Guangdong Province, China (Grant No. 2010B031600237).

Conflict of interest statement

No potential conficts of interest are disclosed.

1. Markou K, Christoforidou A, Karasmanis I, Tsiropoulos G, Triaridis S, Constantinidis I, et al. Laryngeal cancer: epidemiological data from Northern Greece and review of the literature. Hippokratia 2013;17:313-318.

2. De Stefani E, Bofeta P, Deneo-Pellegrini H, Brennan P, Correa P, Oreggia F, et al. Supraglotic and glotic carcinomas: epidemiologically distinct entities? Int J Cancer 2004;112:1065-1071.

3. Machiels JP, Lambrecht M, Hanin FX, Duprez T, Gregoire V, Schmitz S, et al. Advances in the management of squamous cell carcinoma of the head and neck. F1000Prime Rep 2014;6:44.

4. Gaudet MM, Olshan AF, Chuang SC, Berthiller J, Zhang ZF, Lissowska J, et al. Body mass index and risk of head and neck cancer in a pooled analysis of case-control studies in the International Head and Neck Cancer Epidemiology (INHANCE) Consortium. Int J Epidemiol 2010;39:1091-1102.

5. Liu SA, Tsai WC, Wong YK, Lin JC, Poon CK, Chao SY, et al. Nutritional factors and survival of patients with oral cancer. Head Neck 2006;28:998-1007.

6. Nguyen TV, Yueh B. Weight loss predicts mortality afer recurrent oral cavity and oropharyngeal carcinomas. Cancer 2002;95:553-562.

7. Iyengar NM, Kochhar A, Morris PG, Morris LG, Zhou XK, Ghossein R, et al. Impact of obesity on the survival of patients with early-stage squamous cell carcinoma of the oral tongue. Cancer 2014;120:983-991.

8. Franceschi S, Dal Maso L, Levi F, Conti E, Talamini R, La Vecchia C. Leanness as early marker of cancer of the oral cavity and pharynx. Ann Oncol 2001;12:331-336.

9. Takenaka Y, Takemoto N, Nakahara S, Yamamoto Y, Yasui T, Hanamoto A, et al. Prognostic signifcance of body mass index before treatment for head and neck cancer. Head Neck 2015;37:1518-1523.

10. Choi Y, Park B, Jeong BC, Seo SI, Jeon SS, Choi HY, et al. Body mass index and survival in patients with renal cell carcinoma: a clinical-based cohort and meta-analysis. Int J Cancer2013;132:625-634.

11. van Bokhorst-de van der Schuer, van Leeuwen PA, Kuik DJ, Klop WM, Sauerwein HP, Snow GB, et al. Te impact of nutritional status on the prognoses of patients with advanced head and neck cancer. Cancer 1999;86:519-527.

12. Davidson BJ, Root WA, Trock BJ. Age and survival from squamous cell carcinoma of the oral tongue. Head Neck 2001;23:273-279.

13. Reyes-Gibby CC, Anderson KO, Merriman KW, Todd KH, Shete SS, Hanna EY. Survival paterns in squamous cell carcinoma of the head and neck: pain as an independent prognostic factor for survival. J Pain 2014;15:1015-1022.

14. Righini CA, Timi N, Junet P, Bertolo A, Reyt E, Atallah I. Assessment of nutritional status at the time of diagnosis in patients treated for head and neck cancer. Eur Ann Otorhinolaryngol Head Neck Dis 2013;130:8-14.

15. de Melo GM, Ribeiro KC, Kowalski LP, Deheinzelin D. Risk factors for postoperative complications in oral cancer and their prognostic implications. Arch Otolaryngol Head Neck Surg 2001;127:828-833.

16. Fietkau R, Lewitzki V, Kuhnt T, Hölscher T, Hess CF, Berger B, et al. A disease-specifc enteral nutrition formula improves nutritional status and functional performance in patients with head and neck and esophageal cancer undergoing chemoradiotherapy: results of a randomized, controlled, multicenter trial. Cancer 2013;119:3343-3353.

17. Cowey S, Hardy RW. Te metabolic syndrome: A high-risk state for cancer? Am J Pathol 2006;169:1505-1522.

18. van Kruijsdijk RC, van der Wall E, Visseren FL. Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomarkers Prev 2009;18:2569-2578.

19. Olefsky JM, Glass CK. Macrophages, infammation, and insulin resistance. Annu Rev Physiol 2010;72:219-246.

20. Penaranda EK, Shokar N, Ortiz M. Relationship between metabolic syndrome and history of cervical cancer among a US national population. ISRN Oncol 2013;2013:840964.

Cite this article as: Li ZQ, Zou L, Liu TR, Yang AK. Prognostic value of body mass index before treatment for laryngeal squamous cell carcinoma. Cancer Biol Med 2015;12:394-400. doi: 10.7497/j.issn.2095-3941.2015.0043

*These authors contributed equally to this work.

An-Kui Yang

E-mail: yangak@sysucc.org.cn

Received June 5, 2015; accepted September 21, 2015.

Available at www.cancerbiomed.org

Copyright © 2015 by Cancer Biology & Medicine